Clinical Trials

Thoracic

Pathologic Complete Response, Carcinoma, Non-Small-Cell Lung

NCT05750693 2023-03-02

PIK3CA in HER2+ BC and pCR Trial

Phase NA Unknown

58 enrolled

Pathologic Complete Response, Hereditary Sensory and Autonomic Neuropathies

NCT04457700 2022-04-18

CT-based Radiomics of ALN pCR (ypN0) in Breast Cancer Undergoing NAC

218 enrolled

Pathologic Complete Response, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04781725 2021-11-17

INVINCIBLE TRIAL: Intratumoral INT230-6 in Breast Cancer

90 enrolled

Pathologic Complete Response, Breast Neoplasms

NCT05050890 2021-09-30

GIRO_ctDNA

38 enrolled

Pathologic Complete Response, Breast Neoplasms

NCT04917263 2021-06-08

IMMUNOREACT2

544 enrolled

Pathologic Complete Response, Rectal Neoplasms

NCT02907827 2020-12-17

DW-MRi

Phase NA Unknown

Dermatologic

Pathologic Complete Response, Melanoma

NCT03474341 2020-11-16

PRIDE

200 enrolled

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Pathologic Complete Response, Esophageal Neoplasms

NCT03417427 2020-04-27

A Clinical Trail of Demethylation Drug Combined With Chemotherapy in Intermediate-risk AML

Other hematologic neoplasm

Pathologic Complete Response, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT04273477 2020-02-18

MRAI-pCR

Pathologic Complete Response, Rectal Neoplasms

NCT04006041 2019-12-26

Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer

44 enrolled

Esophageal Squamous Cell Carcinoma, Pathologic Complete Response

NCT01863862 2019-03-29

Organ Preservation in Elderly Patients With Rectal Cancer

Phase NA Unknown

90 enrolled

Pathologic Complete Response, Rectal Neoplasms

NCT02511847 2016-04-15

Trial of Afatinib With Paclitaxel for Neoadjuvant Therapy of TNBC and Research of Biomarkers of Afatinib

40 enrolled

Pathologic Complete Response, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02059876 2014-02-12

Dose-dense (Biweekly) Carboplatin Plus Paclitaxel With or Without Trastuzumab as Neoadjuvant Treatment for Breast Cancer

60 enrolled